Terminal Maturation of Orthochromatic Erythroblasts Is Impaired in Burn Patients

Mechanisms of erythropoietin (Epo)–resistant anemia in burn patients are poorly understood. We have recently found that administering a nonselective beta 1,2-adrenergic blocker propranolol (PR) was effective in reversing myelo-erythroid commitment through MafB regulation and increase megakaryocyte e...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Burn Care Res
Autores principales: Hasan, Shirin, Mosier, Michael J, Conrad, Peggie, Szilagyi, Andrea, Gamelli, Richard L, Muthumalaiappan, Kuzhali
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2018
Materias:
Original Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5709235/
https://ncbi.nlm.nih.gov/pubmed/28570310
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/BCR.0000000000000592
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares